Pivot Pharmaceuticals Inc. — Form D
Pivot Pharmaceuticals Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2015-12-08. The offering totals $4.2M, of which $4.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-12-08
- Form: D
- Accession: 0001477932-15-007524
- Industry: Pharmaceuticals
- Exemptions: 05, 06b, 4a5
- Total offering: $4.2M
- Amount sold: $4.2M
- Investors: 9
- Date of first sale: 2015-11-20
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-252581
Issuer
- Name: Pivot Pharmaceuticals Inc.
- CIK: 0001464165
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: 1275 WEST 6TH AVENUE, VANCOUVER, A1, V6H 1A6
- Phone: 604 805 7783
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Pravin Chaturvedi | Director | San Francisco, CA |
| Ahmad Doroudian | Director | Vancouver, A1 |
| Patrick Frankham | Director | Vancouver, A1 |
| Wolfgang Renz | Director | Vancouver, A1 |
| Pravin Chaturvedi | Executive Officer | San Francisco, CA |
| Moira Ong | Executive Officer | Vancouver, A1 |
More